Contralateral Claims Study of Clareon Vivity Pro
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorAlcon Research
About this trial
The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.
Eligibility criteria
Qualifiers
Cataracts in both eyes.
Preoperative corneal astigmatism of less than 1.00 diopter (D) in each eye.
Potential postoperative best corrected visual acuity (BCDVA) of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator.
Other protocol-defined inclusion criteria may apply.
Disqualifiers
Desires monovision correction.
Predicted post-operative residual astigmatism of more than 1D in either eye.
Any ocular or systemic co-morbidity that, in the investigator's medical opinion, may confound the results of this study, prohibit the completion of the study assessments, or increase the risk for the subject.
Other protocol-defined exclusion criteria may apply.
Trial design
Treatments tested in this trial
- Clareon Vivity Pro IOL
- Clareon Vivity IOL
- TECNIS PureSee IOL
- Cataract Surgery
Treatment groups
231 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov